Inovio Biomedical Corporation (NYSE: INO) announced that the company's SynCon H1N1 influenza DNA vaccines achieved protection against current circulating swine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE